Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 24
8-K
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
7 Jun 24
8-K
Amendment to Susi, LLC Lease Agreement
3 Jun 24
ARS
2023 FY
Annual report to shareholders
9 May 24
EFFECT
Notice of effectiveness
9 May 24
S-3/A
Shelf registration (amended)
6 May 24
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
2 May 24
DEF 14A
Definitive proxy
29 Apr 24
S-3
Shelf registration
3 Apr 24
10-K
2023 FY
Annual report
1 Mar 24
8-K
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
8 Feb 24
S-8
Registration of securities for employees
13 Dec 23
8-K
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a
12 Dec 23
8-K
Departure of Directors or Certain Officers
6 Nov 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
3 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Other Events
10 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
4 May 23
DEF 14A
Definitive proxy
28 Apr 23
10-K
2022 FY
Annual report
2 Mar 23
8-K
Other Events
7 Feb 23
8-K
Entry into a Material Definitive Agreement
3 Feb 23
8-K
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022
2 Feb 23
8-K
IRADIMED CORPORATION Announces Preliminary Financial Results for About iRadimed Corporation
18 Jan 23
8-K
Entry into a Material Definitive Agreement
4 Nov 22
8-K
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
3 Nov 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Announces Preliminary Financial Results for Third Quarter 2022
11 Oct 22
8-K
IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel
6 Oct 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
8-K
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
29 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
13 Jun 22
8-K
IRADIMED Names John F. Glenn Chief Financial Officer
26 May 22
10-Q
2022 Q1
Quarterly report
6 May 22
8-K
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
29 Apr 22
Latest ownership filings
4
MONTY K ALLEN
4 Jun 24
144
Notice of proposed sale of securities
3 Jun 24
SC 13G/A
Susi Roger E.
13 Feb 24
SC 13G/A
Nine Ten Capital Management LLC
12 Feb 24
SC 13G
BlackRock Inc.
9 Feb 24
SC 13G/A
Soleus Capital Master Fund, L.P.
2 Feb 24
4
Roger E. Susi
27 Dec 23
4
Roger E. Susi
22 Dec 23
4
Roger E. Susi
20 Dec 23
4
JAMES B HAWKINS
14 Dec 23
144
Notice of proposed sale of securities
14 Dec 23
144
Notice of proposed sale of securities
13 Dec 23
4
Roger E. Susi
13 Dec 23
144
Notice of proposed sale of securities
12 Dec 23
4
JOHN GLENN
11 Dec 23
4
Hilda Frederique Scharen-Guivel
11 Dec 23
4
ANTHONY VUOTO
11 Dec 23
4
MONTY K ALLEN
11 Dec 23
4
JAMES B HAWKINS
11 Dec 23
4
Roger E. Susi
6 Dec 23
4
JAMES B HAWKINS
5 Dec 23
144
Notice of proposed sale of securities
4 Dec 23
144
Notice of proposed sale of securities
1 Dec 23
4
Roger E. Susi
1 Dec 23
4
Roger E. Susi
22 Nov 23
4
Roger E. Susi
16 Nov 23
4
ANTHONY VUOTO
13 Nov 23
144
Notice of proposed sale of securities
13 Nov 23
4
Roger E. Susi
9 Nov 23
4
Roger E. Susi
1 Nov 23
4
Roger E. Susi
27 Oct 23
4
Hilda Frederique Scharen-Guivel
23 Oct 23
4
Roger E. Susi
19 Oct 23
144
Notice of proposed sale of securities
16 Oct 23
4
Roger E. Susi
12 Oct 23
4
Roger E. Susi
5 Oct 23
4
Roger E. Susi
28 Sep 23
4
Roger E. Susi
20 Sep 23
4
Roger E. Susi
13 Sep 23
4
Roger E. Susi
6 Sep 23